Follow last change Mar 2022 re-read 3 minutes ago

OT

Developed for: Prader-Willi syndrome
Investigated by: Epidemiological and Clinical Research Information Network · International Clinical Trials Association · University Hospital, Toulouse

today NCT04283578 · Ph 3

2020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT04283578	Mar 2020 → Oct 2021	Prader-Willi syndrome	University Hospital, Toulouse	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	OT	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04283578 ↗
Route	Intranasal	“intranasal administration of OT” NCT04283578 ↗